IMPLANET: GREEN LIGHT(S) TO MARKET JAZZ LOCK (Orthopedics This Week)
IMPLANET has announced that it has the green light from the FDA—a 510k clearance—as well as the European CE mark for its new Jazz Lock implant. Let the marketing begin.
According to the April 5 2016 news release, “Jazz Lock is the first of an innovative range of band products designed for degenerative spine disorder surgery. This new implant expands the JAZZ technological platform and allows Implanet to broaden its activity to the cervical spine, estimated at over $200 million worldwide. Based on the polyester sublaminar braid platform, Jazz Lock eliminates the mechanism’s locking screw and connecting rod, thanks to a proprietary fastening locking system. Implanet thus offers surgeons a new implant with an optimized and reproducible surgical technique.”
Régis Le Couedic, Implanet’s Product Development & Manufacturing Director, stated, “Constant innovation is the essential component in maintaining our technological advantage. Over the last two years, we have focused our efforts on finalizing our range of Jazz Band implants, notably with the market’s most extensive range of connectors, to ensure compatibility wi...
